|
|
Other links at Articles > Cardiology |
| 1. |
Dose-Ranging Study of Novel Anticoagulant Promising
|
|
|
The addition of apixaban to antiplatelet therapy resulted in an increase in bleeding, but there was also an observed trend toward a reduction in clinically relevant ischemic events, a new dose-ranging study has shown. Heartwire
|
| 5. |
CRT Not Always Being Used in the Right Patients
|
|
|
There is a large variation in the use of cardiac resynchronization therapy throughout the US, and this technology is not always used according to the guidelines, a new registry study shows. Heartwire
|
|
|